pharmaphorum

SEPTEMBER 17, 2020

COVID-19 might have forced pharma to finally fully embrace digital communications, but that doesn’t mean the industry is good at using these platforms yet. In this issue we hear from a variety of KOLs who are leading pharma comms into a new, digital era to get their views on how pharma can best adapt for the post-COVID world.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

JANUARY 8, 2021

According to one analysis, conducted by Global Data, approximately 67% of trial disruptions during the early stages of the pandemic were due to the suspension of enrolment, followed by the delayed start of planned trials at 18.4% and slow enrolment at 14.4%.

104

104

pharmacy mentor

MARCH 12, 2023

Few things altered the course of Community Pharmacy’s destiny more than the digital revolution. In this article, we’ll explore the pharmacy industry landscape before and after the pharmacy digital revolution, with a focus on the impact of digital marketing on patient behaviour and experience. Three words.

Community Pharmacies 97

Community Pharmacies Online Pharmacies Prescription Filling Packaging 97

pharmaphorum

NOVEMBER 23, 2022

But when viewed in isolation, these robust data sets may only provide HTA bodies with a blinkered view of the broader impact of an intervention. Traditionally, HTA submissions leverage significant amounts of data: data about cost, clinical efficacy, benefits, and risks.

52

52

pharmaphorum

OCTOBER 1, 2021

Post-COVID evolution of pharma-doctor digital interactions. M3’s Tim Russell and Maxim Polyakov, together with Digital Futureway’s Heather Hancock, discuss new research on how doctor engagement has been altered by COVID-19. Refining pharma’s digital collaborations with HCPs. Subscribe to future issues of Deep Dive.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies Drug Development 52

pharmaphorum

JUNE 30, 2021

Read on for a look at highlights from ASCO, new approaches to clinical trials, and the transformative impact of digital in oncology. Plus we have a special focus on digital health startups and how digital companies are changing healthcare. . Digital tools key to immuno-oncology’s future: report.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies 52

Quality Matters

MARCH 1, 2024

Currently, USP is exploring other specialized areas within PM, including pharmacogenomics, digital therapeutics, and 3D-printed medications to name a few. The DTx landscape is evolving rapidly, with more than 40 prescription digital therapeutics already available in the U.S. Grand View Research, 2023. in the U.S. Blue Matter.

Labelling 52

Labelling Compounding 52

Pharmaceutical Technology

APRIL 13, 2023

Following the increased use of telemedicine during the Covid-19 pandemic, the potential of digital technologies in communication, data collection, and analysis has become increasingly realised by patients, healthcare systems, and clinical trial sponsors.

Documentation 52

Documentation Communication 52

pharmaphorum

OCTOBER 27, 2022

Ipsen’s Dr Oleksandr Gorbenko and MediPaCe’s Dr Sandeep Bagga examine the ‘impact’ of engaging with patients and how patients view their experiences of discussing impact measurement with life science companies. Co-creating a patient engagement impact framework. The future of clinical research in neurology must be driven by community voices.

Pharmaceutical Companies 104

Pharmaceutical Companies Pharmaceutical Companies 104

pharmaphorum

SEPTEMBER 22, 2022

Cut off from tried and tested methods of engaging with stakeholders, digital, and virtual solutions were thrust into the limelight as the industry proactively accelerated the adoption of technology across all levels of healthcare. The missing pieces of the digital therapeutics puzzle. Gene therapies for prevalent diseases in Europe.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies 52

Viseven

JUNE 29, 2023

The human perception of content was everchanging, from simple newspaper columns or advertisements through radio and TV to today’s variety of digital communication channels. The digital era has expanded the scope of available ways of delivering information to unprecedented values.

Communication 52

Communication 52

pharmaphorum

MAY 6, 2022

Closing the digital expectation gap in pharma. To compete in the digital world, pharma needs to catch up to other industries by creating seamless online experiences, says Takeda’s Jan Deman. Read on to find out how diverse viewpoints are reshaping value, the importance of making patient centricity a reality, and much more.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Express Pharma

APRIL 2, 2024

An analysis by McKinsey has projected that on account of broader adoption of these technologies, the EBIDTA earnings of the Indian pharma industry will go up by 45-75 per cent in the next 10 years. which signifies the next wave of digital transformation in the pharma industry.

Drug Development 59

Drug Development Clinic Management Communication 59

pharmaphorum

FEBRUARY 24, 2022

Read on to find out using digital twins of clinical experiments could help drive progress in virtual biological models, why venture capitalists fell in love with pharma R&D in 2021, and why amplifying patient voices is vital in the rare disease space. Seeing double: the rise of digital twins in life sciences.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

AUGUST 30, 2022

Verista's acquisitions complement the firm's offerings and highlight its focus on Digital Strategy and Innovation (DSI) solutions, where clients are guided through four phases to create their digital strategy: (1) Assess, (2) Deploy and Expand, (3) Automate, (4) Continuous Improvement. United States.

Vaccines 52

Vaccines 52

pharmaphorum

JUNE 3, 2021

The FDA has approved a digital device developed by Cognoa that can be used to diagnose autism spectrum disorder (ASD), just a few weeks after it was filed for approval. ” The post FDA grants swift approval to Cognoa’s digital device for autism diagnosis appeared first on.

Communication 111

Communication 111

pharmaphorum

JULY 7, 2022

pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, high-level interviews and unique research for pharmaceutical companies, biotech firms and the wider healthcare sector. ASCO 2022: Checkpoint inhibitors, Enhertu in spotlight. Read Deep Dive: Oncology in full.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

DECEMBER 14, 2020

COVID-19 – Delivering a pandemic of change to digital medical education. Medscape’s Adrian Duncan explores findings from an FDA trial looking at the impact of digital medical education on antibiotic prescribing. How pharma needs to change for the era of digital health. Subscribe to future issues of Deep Dive.

Pharmaceutical Companies 74

Pharmaceutical Companies Pharmaceutical Companies 74

pharmaphorum

MAY 17, 2021

Restrictions to in-person face-to-face interactions have resulted in increased use of remote and digital channels. The landscape for healthcare professional (HCP) engagement has changed dramatically over the past 12 months, with restrictions to in-person face-to-face meetings resulting in increased use of remote and digital channels.

Communication 72

Communication 72

pharmaphorum

FEBRUARY 26, 2021

We take a look at efforts from charities, the government and digital innovators to boost awareness of rare conditions among GPs and make the clinical pathway smoother for patients. We spoke to him about the lessons he’s taking from his prior jobs and what it means to be an R&D leader in the modern industry. Digitalising drug discovery.

Vaccines 57

Vaccines Communication Pharmaceutical Companies Pharmaceutical Companies 57

pharmaphorum

OCTOBER 28, 2021

Three views on technology improving clinical trial efficiency. pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, high-level interviews and unique research for pharmaceutical companies, biotech firms and the wider healthcare sector. Subscribe to future issues of Deep Dive.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Drug Development 52

PharmaShots

MAY 31, 2023

In addition, our ongoing digital health research highlights progress in developing advanced measurement methods that aim to enhance drug development and personalized care for better patient outcomes. Smriti: Highlight the patient-reported outcomes and StratifyJCV assay analysis for TYSABRI (natalizumab).

Vaccines 40

Vaccines Drug Development 40

pharmaphorum

FEBRUARY 11, 2022

“It’s our representation of tracking the deidentified, which is important from a privacy and compliance point of view,” Sun says. “It For example, Komodo has modules in their solutions suite allowing users to view the diagnostic journey of a patient who’s had a confirmatory diagnosis. “We

104

104

pharmaphorum

MARCH 12, 2021

The industry has tended to view cloud as a way to lower the total cost of ownership of the IT estate by consolidating applications and data centres into a cloud environment. The imperative to innovate also applies to the move into new services and therapies such as digital therapeutics and telehealth.

Vaccines 109

Vaccines Communication Pharmaceutical Companies Pharmaceutical Companies 109

European Pharmaceutical Review

JULY 13, 2023

In EPR’s Future of Bio/Pharmaceutical Analysis online summit last month, Lonza’s Associate Director of R&D discussed the benefits and challenges of using process analytical technology (PAT) in biologics manufacturing. The post How can PAT help advance biologics manufacturing? appeared first on European Pharmaceutical Review.

95

95

pharmaphorum

MARCH 11, 2021

View the webinar* by clicking on the link in the window above or by clicking here. Ignacio is in demand as an international speaker at digital health, clinical research, science and technology events and congresses. The research ecosystem and opportunities for RWE researchers created by the Savana: BREATHE partnership.

108

108

pharmaphorum

MAY 19, 2022

That’s the view of the European Federation of Pharmaceutical Industries and Associations (EFPIA), which has published a list of recommendations aimed at helping the sector get the most of out of the data it holds. Healthcare system information must be better connected. Joined up approach to joined up data.

Drug Development 52

Drug Development 52

Pharma Marketing Network

JULY 21, 2021

The summit consisted of three panel discussions: “Coordinated CX: Moving Beyond Campaign Management,” “Digital Customer Experience and Analytics,” and “The Engagement Matrix: A Holistic View of CX.” What is the objective of this analysis? Across the panels, three consistent themes emerged: Evolution , Integration , and Empathy.

Communication 52

Communication 52

Pharma Marketing Network

JULY 21, 2021

The summit consisted of three panel discussions: “Coordinated CX: Moving Beyond Campaign Management,” “Digital Customer Experience and Analytics,” and “The Engagement Matrix: A Holistic View of CX.” What is the objective of this analysis? Across the panels, three consistent themes emerged: Evolution , Integration , and Empathy.

Communication 52

Communication 52

Express Pharma

DECEMBER 7, 2023

Adoption of digital technologies can help regulatory agencies to drive and maintain compliance by improving their capabilities to analyse data, detect compliance issues, identify risks, promote good regulatory practices, enforce drug quality, facilitate consistent and accurate data documentation, etc.

Generic Medicine 104

Generic Medicine Documentation 104

pharmaphorum

SEPTEMBER 11, 2020

It’s 2020 and the digital revolution is well on its way. Critical decisions are too often being made in a digital data vacuum. In a recent analysis, the Tufts Center for the Study for Drug Development reported that more than two-thirds of all sponsors are using at least four different data sources. New technology insights.

Data Entry 96

Data Entry Documentation Drug Development 96

pharmaphorum

JULY 13, 2021

Leela Barham provides an independent view of patient organisations responses to a NICE online survey and highlights the opportunity for other stakeholders to share their views on NICE through an online survey open until 16 July 2021. Figure 1: Patient organisation respondents views on confidence in NICE processes.

Communication 57

Communication 57

PharmaShots

JUNE 13, 2023

Rui also talked about how Jeuveau stands out from its competitors in the market focusing on its precise effects The interview gives an understanding of how Evolus is evolving its neurotoxin market through its customer-centric approach and innovative digital platform Smriti: To start with please provide details (ROA, MOA, formulations, etc.)

40

40

pharmaphorum

MAY 14, 2021

Experts from ICON give us their views on the past, present and future of NICE’s standing on the world stage. This article appears in our digital magazine, Deep Dive: Market Access 2021. NICE has always been a great reference in HTA for cost-effectiveness analysis (CEA) and cost-utility analysis (CUA) of new medicines,” he says.

Drug Pricing 57

Drug Pricing Documentation Pharmaceutical Companies Pharmaceutical Companies 57

Viseven

JULY 18, 2023

By exploring its benefits, calculation methods, analysis techniques, and future trends, we can uncover its potential to revolutionize patient care. Healthcare organizations can gain a comprehensive view of patient satisfaction, loyalty, and advocacy by understanding NPS and leveraging its benefits.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

APRIL 27, 2022

The trouble is that in a digital-first or hybrid engagement model, this approach is unlikely to yield great success. Benchmarking can play an important role here, giving companies a contextualised view of marketing performance against leading players in the industry. ” About the interviewees. www.csl-uk.com.

Hospitals 113

Hospitals Communication 113

pharmaphorum

NOVEMBER 18, 2022

Biopharma’s digital interactions with healthcare professionals (HCPs) are now a critical part of industry relationships. While many commercial teams wish they had more access to face-to-face meetings with HCPs, a blend of both digital and in-person is key for improving outcomes.

Communication 98

Communication 98